Related Experiment Video

Updated: Jul 18, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

5.1K

E3 Ubiquitin Ligases and Their Therapeutic Applications in Cancers: Narrative Review

Azfar Jamal1,2

  • 1Department of Biology, College of Science, Al-Zulfi-, Majmaah University, Majmaah, Riyadh, Saudi Arabia.

Journal of Pharmacy & Bioallied Sciences
|September 30, 2024
PubMed

Insights

E3 ubiquitin ligases are crucial enzymes in cell regulation and cancer biology. Targeting these ligases with new drugs offers promising strategies for developing novel anti-cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • E3 ubiquitin ligases regulate cellular processes by marking proteins for degradation via the ubiquitin-proteasome system.
  • Dysregulation of the ubiquitin-proteasome system, involving E3 ligases, is implicated in various cancers.
  • E3 ligases' substrate specificity makes them attractive targets for cancer drug development.

Purpose of the Study:

  • To review the critical roles of E3 ubiquitin ligases in cancer biology.
  • To examine existing bioactive compounds targeting E3 ligases for cancer therapy.

Main Methods:

  • Literature review of E3 ligase function in cancer.
  • Analysis of current drug discovery efforts targeting E3 ligases.

Main Results:

  • E3 ligases are key regulators of oncogenic and tumor-suppressive proteins.
  • Several bioactive substances targeting E3 ligases show potential as anti-cancer agents.

Conclusions:

  • E3 ligases are vital targets for novel cancer therapeutics.
  • Targeted therapies modulating E3 ligase activity represent a promising frontier in oncology.
Keywords:
E3 ligaseMDM2NEDD4RING (really interesting new genes)ubiquitin

More Related Videos

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases06:30

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Published on: August 27, 2021

3.0K
Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

2.5K

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...